Expression of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase in Penile Cancer

ZHAO Feng; TANG Jie; GOU Hong-feng; LI Long-hao; DONG Hang; CHEN Ye; CHENG Ke; DING Jing; CHEN Xin; MEN Hai-Tao; LIU Ji-yan

Volume 44 Issue 5

Sep. 2013

Turn off MathJax

Article Contents

References

JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) > 2013 > 44(5): 756-759.

ZHAO Feng, TANG Jie, GOU Hong-feng, et al. Expression of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase in Penile Cancer[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(5): 756-759.

Citation:

PDF (1306 KB)

Expression of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase in Penile Cancer

Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China

More Information

Received Date: January 23, 2013
Revised Date: May 07, 2013
Published Date: September 19, 2013

Abstract

- Penile cancer,
- Thymidylate synthase,
- Dihydropyrimidine dehydrogenase,
- Fluorouracil

FullText(HTML)

References (16)

References

[1]	Pizzocaro G, Algaba F, Solsona E,et al. EUA penile cancer guidelines 2009. Eur Urol,2010;57(6):1002-1012.
[2]	Leijte JA,Kirrander P, Antonini N, et al. Recurrence patterns of squamous cell carcinoma of the penis:recommendations for follow-up based on a two-center analysis of 700 patients.Eur Urol,2008;54(1):161-168.
[3]	Haas GP,Blumenstein BA,Gagliano RG,et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis:a Southwest OncologyGroup study. J Urol,1999;161(6):1823-1825.
[4]	Shammas FV, Ous S, Fossa SD.Cisplatin and 5-fluorouracil in advanced cancer of the penis.J Urol,1992;147(3):630-632.
[5]	Pizzocaro G, Nicolai N, Milani A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer:preliminary results.Eur Urol,2009;55(3):546-551.
[6]	Diasio RB,Johnson MR.The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil. Pharmacology,2000;61(3):199-203.
[7]	Maring JG, Groen HJ, Wachters FM, et al. Genetic factors influencing pyrimidine-antagonist chemotherapy. Pharmaco-genomics J,2005;5(4):226-243.
[8]	卓丽娟, 施作霖, 肖志芸等.TS、TP在结直肠癌中的表达及其临床病理学意义.山西医科大学学报,2007;38(6):533-536.
[9]	马韬, 于颖彦, 计骏等. 二氢嘧啶脱氢酶(DPD)与胸苷酸合成酶(TS)在结直肠癌中的表达及预后价值.现代肿瘤医学,2009;17(7):1292-1295.
[10]	Terashima M, Irinoda T, Fujiwara H, et al. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer. Anticancer Res,2002;22(2A):761-768.
[11]	张大红, 王琳, 乔伟丽.PowerVision法与SABC法在免疫组织化学染色中的比较.徐州医学院报,2004;24(20):329-331.
[12]	Johnston PG, Lenz HJ, Leichman CG,et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res,1995;55(7):1407-1412.
[13]	Shirota Y,Stoehlmacher J, Brabender J,et al.ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol,2001;19(23):4298-4304.
[14]	Tateishi Y, Tatemoto Y, Ohno S, et al.Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy. Cancer Lett,2009;274(2):187-193.
[15]	Ma T, Zheng BY,Ji YB,et al.Expression and clinical significance of thymidinephosphorylase and dihydropyrimidine dehydrogenase in colorectal carcinoma.World Chinese Journal of Digestology,2006;14(12):1183-1187.
[16]	刘新兰, 丛芳圆, 王宁菊等.胃癌组织中TS、DPD的表达及其临床意义. 陕西医学杂志,2011;40(3):270-273.

Relative Articles

Supplements (0)

Cited By

Get Citation

PDF

XML

Article views (2285) PDF downloads (26)

Expression of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase in Penile Cancer

References

Catalog

Export File

Citation

Format

Content